Business · 19/12/2005Updated: 10/17/2026 · 1 min read
FDA Amends Animal Drug Regulations for Tiamulin
Summary
The FDA is updating its regulations to reflect a change in sponsorship for four new animal drug applications for tiamulin, from Boehringer Ingelheim Vetmedica to Novartis Animal Health US.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →